Skip to Main

Search

Results 911 to 920 of 1,058 for ""

Scientists find method to boost CRISPR efficiency: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2019/boosting-crispr-efficiency.html

Scientists have developed a method to boost the efficiency of CRISPR gene editing in Duchenne muscular dystrophy (DMD), according to a study that could have implications for optimizing gene therapies for other diseases.

UTSW researchers identify new mechanism to reduce inflammation: Newsroom, UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2019/reducing-inflammation.html

UT Southwestern researchers have identified two proteins that act as gatekeepers to dampen a potentially life-threatening immune response to chronic infection.

Targeted radiation controls metastatic kidney cancer: Newsroom - UT Southwestern, Dallas, TX

https://www.utsouthwestern.edu/newsroom/articles/year-2019/targeted-radiation-kidney-cancer.html

Investigators report an innovative strategy for treating advanced kidney cancer.

Study proves hepatitis C drugs reduce liver-related deaths by nearly 50%: Newsroom - UT Southwestern, Dallas, TX

https://www.utsouthwestern.edu/newsroom/articles/year-2019/hepatitis-c-drugs-reduce-liver-related-deaths.html

Antiviral drugs for hepatitis C reduce liver-related deaths by nearly 50 percent in patients with a history of liver cancer.

Need to check patient's jugular venous pressure? There's an app for that : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/jugular-venous-pressure.html

A new report from cardiologists at UT Southwestern raises the hope that doctors will be able to visually check the jugular venous pressure of heart failure patients remotely, using the camera on a smartphone.

FDA-approved drugs could help fight COVID-19 - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/fda-approved-drugs-could-help-fight-covid19.html

Drugs that are already approved by the U.S. Food and Drug Administration (FDA) could hold promise in fighting the new infection known as coronavirus disease 2019 (COVID-19)...

Drug combination could eliminate side effects of once-popular diabetes treatment: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/drug-combination-could-eliminate-diabetes-treatment-side-effects.html

Study shows how an effective but largely abandoned treatment for Type 2 diabetes could be used again in combination with another drug to eliminate problematic side effects.

A sole mate to prevent diabetic foot ulcers: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/diabetic-foot-ulcers.html

A new cooling insole developed by UT Southwestern scientists reduced the foot temperature of patients with diabetic neuropathy by several degrees, diminishing a significant risk factor for diabetic foot ulcers.

Boosting the immune system's appetite for cancer - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/boosting-the-immune-systems-appetite-for-cancer.html

A combination of immunotherapy agents that encourages some immune cells to eat cancer cells and alert others to attack tumors put mice with a deadly type of brain cancer called glioblastoma into long-term remission

A step closer to eradicating malaria - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/a-step-closer-to-eradicating-malaria.html

Strategies that treat households in the broad vicinity of a recent malaria case with anti-malarial drugs, insecticides, or both could significantly reduce malaria in low-transmission settings.